|
CH535201A
(de)
|
1969-12-19 |
1973-03-31 |
Bristol Myers Co |
Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
|
|
JPS632932A
(ja)
|
1986-06-23 |
1988-01-07 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US4994467A
(en)
|
1989-05-31 |
1991-02-19 |
Zimmerman Andrew W |
Treating autism and other developmental disorders in children with NMDA receptor antagonists
|
|
DE4312016A1
(de)
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stabile Ketamin-Lösungen
|
|
US5543434A
(en)
|
1994-02-25 |
1996-08-06 |
Weg; Stuart L. |
Nasal administration of ketamine to manage pain
|
|
DK0814790T3
(da)
|
1995-02-24 |
2003-11-10 |
Stuart L Weg |
Indgivelse af ketamin med henblik på afgiftning
|
|
CA2230690C
(fr)
|
1995-08-30 |
2008-12-23 |
Stuart L. Weg |
Administration de ketamine pour gerer la douleur et reduire la dependance aux medicaments
|
|
FR2739294B1
(fr)
|
1995-09-29 |
1998-01-16 |
Lhd Lab Hygiene Dietetique |
Embout nasal de securite
|
|
DE19619665C2
(de)
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemattrennung von Ketamin
|
|
DE19723133A1
(de)
|
1997-06-03 |
1998-12-10 |
Caideil M P Teoranta Tourmakea |
Austragvorrichtung für Medien
|
|
FR2764807B1
(fr)
|
1997-06-18 |
1999-08-20 |
Valois Sa |
Dispositif de distribution nasale d'un produit fluide ou pulverulent
|
|
RU2224523C2
(ru)
|
1998-07-24 |
2004-02-27 |
Сео Хонг Ю |
Водный раствор, содержащий желчную кислоту, и способ его получения
|
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
|
US6176242B1
(en)
|
1999-04-30 |
2001-01-23 |
Medtronic Inc |
Method of treating manic depression by brain infusion
|
|
US6017961A
(en)
|
1999-07-08 |
2000-01-25 |
Flores; John Anthony |
Ketamine and n-butyl-p-aminobezoate in PLO
|
|
EP1103256A1
(fr)
|
1999-11-26 |
2001-05-30 |
Claudius Dr. med. Böck |
Utilisation de la kétamine pour le traitement de la dysfonction immunitaire neuroendocrine et du psyhosyndrome algogénique
|
|
EP1328214A4
(fr)
|
2000-09-20 |
2009-07-29 |
Shahinian Lee Jr |
Preparations et medications nasales, inhalables et ophtalmiques locales a conservation spontanee
|
|
US6881731B1
(en)
|
2000-10-23 |
2005-04-19 |
Shanbrom Technologies, Llc |
Enhancers for microbiological disinfection
|
|
CA2529857A1
(fr)
|
2002-07-30 |
2004-02-05 |
Peter Migaly |
Combinaison de therapie pour la depression, la prevention du suicide et divers troubles medicaux et psychiatriques
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
JP2006510618A
(ja)
|
2002-11-18 |
2006-03-30 |
ヤウポン セラピューティクス，インコーポレーテッド |
ノルケタミンおよびケタミン／ノルケタミンプロドラッグの鎮痛的使用
|
|
US7687080B2
(en)
|
2002-11-25 |
2010-03-30 |
Taraxos Inc. |
Treatment of neuropathy
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
US8082173B2
(en)
*
|
2003-05-22 |
2011-12-20 |
Cecil Kost |
Drug sample fulfillment architecture
|
|
US20050095277A1
(en)
|
2003-06-25 |
2005-05-05 |
Binnur Ozturk |
Neuropathy cream
|
|
US20040265364A1
(en)
|
2003-06-25 |
2004-12-30 |
Binnur Ozturk |
Neuropathy cream
|
|
WO2005079756A2
(fr)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Methodes et compositions de traitement de troubles psychiatriques
|
|
JP5607291B2
(ja)
|
2004-11-24 |
2014-10-15 |
メダ ファーマシューティカルズ インコーポレイテッド |
アゼラスチンを含む組成物およびその使用方法
|
|
US20060223788A1
(en)
|
2005-03-29 |
2006-10-05 |
Cathcart Clifton H |
Analgesic composition for topical use
|
|
JP5026411B2
(ja)
|
2005-06-01 |
2012-09-12 |
エスエイチエル グループ エービー |
薬物送達装置
|
|
US20060276550A1
(en)
|
2005-06-03 |
2006-12-07 |
Dileep Bhagwat |
Topical compositions of ketamine and butamben and methods of their use
|
|
AU2007229866A1
(en)
|
2006-03-22 |
2007-10-04 |
Mount Sinai School Of Medicine |
Intranasal administration of ketamine to treat depression
|
|
WO2007123945A2
(fr)
|
2006-04-21 |
2007-11-01 |
Aradigm Corporation |
Dispositif monodose de distribution intrapulmonaire de médicaments
|
|
US20090306137A1
(en)
|
2006-05-22 |
2009-12-10 |
Wolfgang Curt D |
Treatment for depressive disorders
|
|
DE102007009888A1
(de)
|
2007-02-28 |
2008-09-04 |
Hermann, Holger Lars, Dr. |
Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
|
|
BRPI0809843A2
(pt)
|
2007-04-26 |
2014-09-23 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica e uso de um composto"
|
|
US7745665B2
(en)
*
|
2007-06-04 |
2010-06-29 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
WO2009131794A1
(fr)
|
2008-03-27 |
2009-10-29 |
University Of Kentucky Research Foundation |
Combinaisons de co-médicament opioïdekétamine et norkétamine dans la gestion de la douleur
|
|
NZ588895A
(en)
|
2008-05-13 |
2012-07-27 |
Clarassance Inc |
Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
|
|
US20110038807A1
(en)
|
2009-08-14 |
2011-02-17 |
Demitri Papolos |
Compositions and methods for treating bipolar disorder
|
|
US20120225949A1
(en)
|
2009-08-14 |
2012-09-06 |
Demitri Papalos |
Compositions and methods for treating bipolar disorder
|
|
EP2992877A1
(fr)
|
2010-06-15 |
2016-03-09 |
Grünenthal GmbH |
Combinaison pharmaceutique pour le traitement de la douleur
|
|
WO2013003669A2
(fr)
|
2011-06-30 |
2013-01-03 |
University Of South Florida |
Compositions, méthodes d'utilisation et méthodes de traitement
|
|
WO2013056229A1
(fr)
|
2011-10-14 |
2013-04-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Utilisation de (2r, 6r)-hydroxynorkétamine, (s)-déshydronorkétamine et autres métabolites déshydro et hydroxylés stéréo-isomères de (r,s)-kétamine dans le traitement de la dépression et de la douleur neuropathique
|
|
RU2622082C2
(ru)
|
2011-11-14 |
2017-06-09 |
Нестек С.А. |
Анализы и способы выбора режима лечения пациента с депрессией
|
|
US20130209585A1
(en)
|
2012-02-13 |
2013-08-15 |
Stanley Kim |
Topical NMDA Antagonist Formulations for the Treatment of Peripheral Neuropathy
|
|
WO2013138322A1
(fr)
*
|
2012-03-12 |
2013-09-19 |
Janssen Pharmaceutica Nv |
Eskétamine dans le traitement de la dépression réfractaire ou résistante aux traitements
|
|
AU2016203771A1
(en)
|
2012-03-13 |
2016-06-23 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
EP2830604A4
(fr)
|
2012-03-30 |
2015-08-19 |
Gen Hospital Corp |
Compositions comprenant de la scopolamine et de la kétamine dans le traitement de la dépression
|
|
US20140079740A1
(en)
|
2012-08-02 |
2014-03-20 |
ClinPharm Support GmbH |
Oral transmucosal adminstration forms of s-ketamine
|
|
KR20150096370A
(ko)
|
2012-08-23 |
2015-08-24 |
스튜어트 엘. 웨그 |
항불안제 조성물, 제형 및 사용방법
|
|
FR2994844B1
(fr)
|
2012-08-31 |
2015-01-02 |
Assist Publ Hopitaux De Paris |
Formulation gelifiante a base de ketamine
|
|
NZ619257A
(en)
|
2012-10-08 |
2015-07-31 |
Auckland Uniservices Ltd |
Ketamine derivatives
|
|
ES2484068B1
(es)
|
2013-02-08 |
2015-04-16 |
Ana MÍNGUEZ MARTÍ |
Una composición farmacéutica que contiene ketamina y amitriptilina
|
|
US20140274981A1
(en)
|
2013-03-15 |
2014-09-18 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition of s-ketamine hydrochloride
|
|
DK2983787T3
(da)
|
2013-04-12 |
2020-01-06 |
Icahn School Med Mount Sinai |
Fremgangsmåde til behandling af posttraumatisk stresssygdom
|
|
CA2922507C
(fr)
|
2013-08-26 |
2022-07-05 |
Amorsa Therapeutics, Inc. |
Dose orale a couche unique de ketamine neuro-attenuante
|
|
HUE056378T2
(hu)
|
2013-09-13 |
2022-02-28 |
Univ Chiba Nat Univ Corp |
R-Ketamin és sójának alkalmazása gyógyszerekként
|
|
CN103705909A
(zh)
|
2013-12-16 |
2014-04-09 |
陈镜伊 |
一种无痛人流用药
|
|
WO2015101693A1
(fr)
|
2013-12-31 |
2015-07-09 |
Servicio Andaluz De Salud |
Compositions et préparations combinées pour le traitement des douleurs oropharyngées
|
|
EP3094312B1
(fr)
|
2014-01-14 |
2019-03-13 |
Children's Hospital Medical Center |
Compositions comprenant de la kétamine pour le traitement d'un trouble du spectre de l'autisme
|
|
PL3287124T3
(pl)
|
2014-04-17 |
2023-02-20 |
Ketabon Gmbh |
Doustna postać dawkowania ketaminy
|
|
MX2016013787A
(es)
|
2014-05-04 |
2017-07-24 |
Firmenich & Cie |
Productos alimenticios y bebidas que estan saborizados.
|
|
FR3023188B1
(fr)
|
2014-07-04 |
2016-08-19 |
Aptar France Sas |
Dispositif de distribution de produit fluide.
|
|
KR20170040800A
(ko)
|
2014-08-13 |
2017-04-13 |
얀센 파마슈티카 엔.브이. |
우울증 치료 방법
|
|
AU2015318123A1
(en)
|
2014-09-15 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression
|
|
WO2016109427A1
(fr)
|
2014-12-31 |
2016-07-07 |
Icahn School Of Medicine At Mount Sinai |
Procédé de maintien de l'effet antidépresseur de la kétamine avec du lithium
|
|
WO2016172672A1
(fr)
|
2015-04-24 |
2016-10-27 |
Icahn School Of Medicine At Mount Sinai |
Procédé de traitement d'idéation suicidaire
|
|
CN104798728A
(zh)
|
2015-05-08 |
2015-07-29 |
南京中医药大学 |
产后抑郁动物模型的建立方法及其应用
|
|
US20160332962A1
(en)
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20160338977A1
(en)
*
|
2015-05-20 |
2016-11-24 |
Janssen Pharmaceutica Nv |
Methods and kits for treating depression
|
|
CN107847469A
(zh)
|
2015-06-27 |
2018-03-27 |
美国神农制药责任有限公司 |
氯胺酮透皮递送系统
|
|
US20180296478A1
(en)
|
2016-02-12 |
2018-10-18 |
Synergistic Therapeutics, Llc |
Sublingual antidepressant and antianxiety tablet
|
|
US20180042936A1
(en)
|
2016-03-18 |
2018-02-15 |
Genomind, Inc. |
Maintenance therapy using tianeptine
|
|
KR20240011237A
(ko)
*
|
2017-12-22 |
2024-01-25 |
얀센 파마슈티카 엔브이 |
우울증 치료를 위한 에스케타민
|
|
JP2022524008A
(ja)
*
|
2019-03-05 |
2022-04-27 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
うつ病の治療のためのエスケタミン
|